HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angela Tincani Selected Research

Biomarkers (Surrogate Marker)

5/2022Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners.
5/2015State of the art: Reproduction and pregnancy in rheumatic diseases.
5/2015Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
10/2011Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Angela Tincani Research Topics

Disease

50Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
12/2022 - 02/2005
42Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 02/2005
40Autoimmune Diseases (Autoimmune Disease)
07/2021 - 02/2005
26Thrombosis (Thrombus)
12/2022 - 05/2006
16Rheumatoid Arthritis
01/2021 - 08/2007
11Lupus Nephritis
11/2021 - 05/2007
10Systemic Scleroderma (Systemic Sclerosis)
07/2021 - 06/2009
9Inflammation (Inflammations)
01/2021 - 06/2006
8Rheumatic Diseases (Rheumatism)
12/2019 - 02/2005
7COVID-19
01/2022 - 01/2020
6Proteinuria
11/2021 - 05/2007
6Arthritis (Polyarthritis)
01/2021 - 11/2010
6Hemorrhage
01/2021 - 06/2012
6Congenital heart block
01/2019 - 09/2005
5Hypertension (High Blood Pressure)
11/2021 - 06/2011
5Pregnancy Complications
10/2019 - 12/2012
5Neonatal Systemic lupus erythematosus
01/2019 - 09/2005
5Spontaneous Abortion (Miscarriage)
01/2018 - 11/2006
5Pre-Eclampsia (Preeclampsia)
11/2016 - 02/2009
4Venous Thrombosis (Deep-Vein Thrombosis)
05/2022 - 05/2018
4Myositis (Idiopathic Inflammatory Myopathies)
03/2021 - 03/2013
4Infections
10/2020 - 04/2013
4Glomerulonephritis
01/2020 - 07/2010
4Adult-Onset Still's Disease
01/2020 - 08/2016
3Connective Tissue Diseases (Connective Tissue Disease)
05/2022 - 01/2018
3Thrombocytopenia (Thrombopenia)
01/2022 - 06/2006
3Undifferentiated Connective Tissue Diseases
10/2020 - 01/2011
3Giant Cell Arteritis (Horton Disease)
01/2020 - 01/2012
3Infertility (Sterility)
12/2019 - 11/2006
3Dermatomyositis (Dermatopolymyositis)
01/2016 - 04/2012
3Communicable Diseases (Infectious Diseases)
04/2010 - 02/2005
2Immunoglobulin G4-Related Disease
05/2022 - 01/2018
2Rupture
07/2021 - 12/2014
2Deglutition Disorders (Dysphagia)
03/2021 - 02/2017
2Pericarditis
05/2020 - 08/2016
2Vasculitis (Vasculitides)
01/2020 - 01/2012
2Learning Disabilities (Learning Disability)
01/2020 - 05/2012
2Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 09/2010
2Diabetes Mellitus
12/2018 - 01/2011

Drug/Important Bio-Agent (IBA)

50AntibodiesIBA
01/2022 - 02/2005
38Antiphospholipid AntibodiesIBA
09/2022 - 09/2005
33AutoantibodiesIBA
07/2021 - 06/2006
17Immunoglobulin G (IgG)IBA
01/2021 - 09/2005
14Hydroxychloroquine (Plaquenil)FDA LinkGeneric
12/2022 - 02/2005
8Phospholipids (Phosphatides)FDA LinkGeneric
07/2020 - 02/2005
8Pharmaceutical PreparationsIBA
01/2020 - 01/2006
7belimumabIBA
11/2021 - 10/2014
7Complement System Proteins (Complement)IBA
06/2021 - 09/2009
7Abatacept (Orencia)FDA Link
01/2021 - 04/2014
6CytokinesIBA
05/2022 - 04/2010
6AntigensIBA
01/2020 - 10/2011
6Glycoproteins (Glycoprotein)IBA
01/2019 - 05/2006
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022 - 01/2016
5Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
01/2020 - 06/2011
5Vitamin DFDA LinkGeneric
01/2018 - 09/2010
5DNA (Deoxyribonucleic Acid)IBA
01/2017 - 08/2007
4Biomarkers (Surrogate Marker)IBA
05/2022 - 10/2011
4Biological ProductsIBA
05/2022 - 09/2015
4Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 10/2019
4SiliconesIBA
07/2021 - 01/2017
4EnzymesIBA
03/2021 - 11/2006
4Intravenous Immunoglobulins (IVIG)FDA Link
03/2021 - 07/2007
4EpitopesIBA
01/2021 - 01/2018
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 09/2014
4Prednisone (Sone)FDA LinkGeneric
01/2020 - 01/2017
4Adrenal Cortex Hormones (Corticosteroids)IBA
12/2019 - 06/2006
3ChemokinesIBA
05/2022 - 08/2020
3Immunoglobulins (Immunoglobulin)IBA
05/2022 - 09/2011
3RivaroxabanIBA
01/2021 - 01/2018
3Warfarin (Coumadin)FDA LinkGeneric
01/2021 - 01/2018
3Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2021 - 01/2019
3Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2013
3ColchicineFDA LinkGeneric
10/2020 - 01/2020
3Vitamin KFDA Link
12/2019 - 01/2019
3Immunoglobulin A (IgA)IBA
01/2019 - 01/2012
3InterferonsIBA
12/2018 - 04/2010
3Immunosuppressive Agents (Immunosuppressants)IBA
08/2018 - 09/2007
3Antirheumatic Agents (DMARD)IBA
08/2016 - 01/2015
3Immunoglobulin M (IgM)IBA
01/2012 - 08/2007
3SS-A antibodiesIBA
03/2011 - 09/2005
2AnticoagulantsIBA
12/2022 - 01/2017
2Thromboplastin (Tissue Factor)IBA
12/2021 - 10/2007
2Antimalarials (Antimalarial Agents)IBA
11/2021 - 03/2017
2Prednisolone (Predate)FDA LinkGeneric
11/2021 - 10/2019
2CreatinineIBA
11/2021 - 08/2015
2RNA Polymerase IIIIBA
07/2021 - 06/2009
2Anti-Idiotypic AntibodiesIBA
01/2021 - 02/2008
2Deoxyribonucleases (DNase)FDA Link
01/2021 - 01/2020
2Iodide Peroxidase (Deiodinase)IBA
01/2021 - 11/2006
2VaccinesIBA
10/2020 - 01/2017
2Azathioprine (Imuran)FDA LinkGeneric
09/2020 - 01/2020
2Interleukin-1 (Interleukin 1)IBA
01/2020 - 01/2017
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2020 - 01/2019
2Histones (Histone)IBA
08/2018 - 08/2015
2Antinuclear AntibodiesIBA
08/2018 - 02/2005
2Rheumatoid FactorIBA
08/2018 - 04/2014
2Annexin A5IBA
05/2018 - 11/2006
2Cardiolipins (Cardiolipin)IBA
05/2018 - 08/2007

Therapy/Procedure

25Therapeutics
12/2022 - 11/2006
2Breast Implants (Breast Implant)
07/2021 - 10/2020